Ex vivo method for determining potential GLP-2 receptor modulators

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7977061
APP PUB NO 20100003703A1
SERIAL NO

12358123

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein is a method for measuring the contractility of intestinal tissue upon treatment with GLP-2 or a GLP-2 ligand. Also disclosed is an assay which directly measures the activity of GLP-2 or GLP-2 ligands ex vivo and permits the screening of putative GLP-2 ligands in native tissue.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NPS PHARMACEUTICALS INCUTAH USA

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Demchyshyn, Lidia Toronto, CA 4 0
Wang, Hong Hamilton, CA 1168 13527

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation